This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

RANDAL S. WEBER, MD
Houston, Tex

Arch Otolaryngol Head Neck Surg. 1990;116(8):902-903.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Dr Scott Stern and colleagues, M. D. Anderson Cancer Center, Houston, Tex, recently presented their work on the vascular effects of chloroaluminum sulfonated phthalocyanine, a new photosensitizer for photodynamic therapy. The paper was presented at the annual spring meeting of the American Society for Head and Neck Surgery, Palm Beach, Fla. According to these investigators, chloroaluminum sulfonated phthalocyanine has many advantages over the clinically available photosensitizer, dihematoporphyrin ether. These advantages include greater depth of tissue penetration and lack of cutaneous photosensitivity.

Utilizing healing skin incisions of neovascularization in the rat model, the effects of chloroaluminum sulfonated phthalocyanine photodynamic therapy were compared with the effect of chloroaluminum sulfonated phthalocyanine alone, light alone, and no treatment. Results showed a marked increase in vascularity immediately, and up to 12 hours after, photodynamic therapy, as measured by reflectance spectrophotometry. Histologically, the initial increase in vascularity was apparently due to hemorrhage, but marked vasodilation was . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?